Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles

References

• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• KerbelRSAntiangiogenic therapy: a universal chemosensitization strategy for cancer?Science200631257771171117516728631
   PubMed Web of Science ®Google Scholar
• CaoSDurraniFATothKRustumYMSeshadriMBevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenograftsOral oncol201147645946621530364
   PubMedGoogle Scholar
• YooDSKirkpatrickJPCraciunescuOProspective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancerClin Cancer Res20121851404141422253412
   PubMed Web of Science ®Google Scholar
• SenninoBMcDonaldDMControlling escape from angiogenesis inhibitorsNat Rev Cancer2012121069970923001349
   PubMed Web of Science ®Google Scholar
• BergersGHanahanDModes of resistance to anti-angiogenic therapyNat Rev Cancer20088859260318650835
   PubMed Web of Science ®Google Scholar
• MulderWJvan der SchaftDWHautvastPAEarly in vivo assessment of angiostatic therapy efficacy by molecular MRIFASEB J200721237838317202248
   PubMed Web of Science ®Google Scholar
• BrowderTButterfieldCEKralingBMAntiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancerCancer Res20006071878188610766175
   PubMed Web of Science ®Google Scholar
• HoodJDChereshDARole of integrins in cell invasion and migrationNat Rev Cancer2002229110012635172
   PubMed Web of Science ®Google Scholar
• BrooksPCClarkRAChereshDARequirement of vascular integrin alpha v beta 3 for angiogenesisScience199426451585695717512751
   PubMed Web of Science ®Google Scholar
• BackerMVBackerJMImaging key biomarkers of tumor angiogenesisTheranostics20122550251522737188
   PubMedGoogle Scholar
• EllegalaDBLeong-PoiHCarpenterJEImaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v) beta3Circulation2003108333634112835208
   PubMed Web of Science ®Google Scholar
• BeerAJGrosuALCarlsenJ[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neckClin Cancer Res20071322 Pt 16610661618006761
   PubMedGoogle Scholar
• ParkJALeeJJJungJCGd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agentChembiochem20089172811281318956393
   PubMedGoogle Scholar
• DeshpandeNRenYFoygelKRosenbergJWillmannJKTumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imagingRadiology2011258380481121339349
   PubMedGoogle Scholar
• LiuYYangYZhangCA concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin alphav-beta3 with magnetic probesInt J Nanomedicine201381083109323515638
   PubMed Web of Science ®Google Scholar
• DeberghIVan DammeNDe NaeyerDMolecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting alphavbeta 3 integrinAnn Surg Oncol20142162097210424356800
   PubMedGoogle Scholar
• LiuZLiuSNiuGWangFLiuSChenXOptical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkersMol Imaging201091212920128995
   PubMedGoogle Scholar
• HuangJZhongXWangLYangLMaoHImproving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticlesTheranostics2012218610222272222
   PubMed Web of Science ®Google Scholar
• HuangXZhuangJChenDGeneral strategy for designing functionalized magnetic microspheres for different bioapplicationsLangmuir20092519116571166319694417
   PubMed Web of Science ®Google Scholar
• ZhangCJugoldMWoenneECSpecific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scannerCancer Res20076741555156217308094
   PubMed Web of Science ®Google Scholar
• JiangTZhangCZhengXNoninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scannerInt J Nanomedicine2009424124920011241
   PubMed Web of Science ®Google Scholar
• ZhangFHuangXZhuLNoninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nano-particlesBiomaterials201233215414552222560667
   PubMed Web of Science ®Google Scholar
• ChenWTShihTTChenRCTuSYHsiehWYYangPCIntegrin alphavbeta3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor modelMol Imaging201211428630022954145
   PubMedGoogle Scholar
• SchmiederAHCaruthersSDZhangHThree-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse modelFASEB J200822124179418918697838
   PubMed Web of Science ®Google Scholar
• LaurentSForgeDPortMMagnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applicationsChem Rev200810862064211018543879
   PubMed Web of Science ®Google Scholar
• CuiYLiuHLiangSThe feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDGOncotarget2016719272432725427029065
   PubMedGoogle Scholar
• SunXYanYLiuS18F-FPPRGD2 and 18F-FDG PET of response to Abraxane Ther2011521140146
   Google Scholar
• Bogdanowich-KnippSJChakrabartiSWilliamsTDDillmanRKSiahaanTJSolution stability of linear vs. cyclic RGD peptidesJ Pept Res199953553054110424348
   PubMedGoogle Scholar
• TerrySYAbirajKLokJCan 111In-RGD2 monitor response to therapy in head and neck tumor xenografts?J Nucl Med201455111849185525349221
   PubMed Web of Science ®Google Scholar
• SchmiederAHWinterPMWilliamsTAMolecular MR imaging of neovascular progression in the Vx2 tumor with alphavbeta3-targeted paramagnetic nanoparticlesRadiology2013268247048023771914
   PubMedGoogle Scholar
• WenQLMengMBYangBEndostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in miceCancer Sci200910081510151919459845
   PubMed Web of Science ®Google Scholar
• GuanYLiAXiaoWThe efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinomaOncotarget2015632339263393426418895
   PubMedGoogle Scholar
• ZhouJWangLXuXTuYQinSYinYAntitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft modelsOncol Lett20124597698023162635
   PubMedGoogle Scholar